Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: Apr 5, 2022
Date Accepted: Aug 29, 2022
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Preliminary investigation of Shift, a novel smartphone application to support junior doctors’ mental health and wellbeing: Examination of symptom progression, usability, and acceptability after one month of use
ABSTRACT
Background:
Shift is a novel smartphone application (app) to provide a digital-first mental health resource to junior doctors. It contains psychoeducational material, cognitive behavioural modules, guided mediations, information on common work stressors, and a section on help-seeking options for psychological problems through workplace and private avenues.
Objective:
To conduct a preliminary investigation of the usage and potential effectiveness of Shift on depressive and anxiety symptoms (primary outcomes), and work and social functioning, coronavirus safety concerns, and help-seeking (secondary outcomes). This study also sought feedback on whether Shift was seen as an acceptable tool.
Methods:
Junior doctors in New South Wales, Australia were approached through promotional activities from the Ministry of Health, specialist medical colleges, and social media advertisements between June and August 2020. Consenting participants provided online baseline data, used the Shift app for 30 days, and were asked to complete a post-study online questionnaire. Outcomes were analysed under the ITT principle.
Results:
A total of 222 (156/222 female, 70%; mean age = 29.2 years) junior doctors provided full baseline data. Of those, 198/222 (89%) downloaded the app, logged into the app about 6 times (M = 5.68, SD = 7.51), completed 4 in-app activities (M = 3.77, SD = 4.36), and spent a total of one hour on in-app activities (M = 52:23, SD = 6:00:18) over 30 days. Post-intervention data were provided by 54/222 (24%) of participants. Depressive and anxiety symptoms significantly decreased between the pre- and post-assessment points as expected, however, doctors’ coronavirus safety concerns significantly increased. Work and social functioning, coronavirus concerns for family and friends, and help seeking did not change significantly. There was no significant relationship between symptom changes and app usage (number of logins, days between first and last login, and total activity time). Most post-study completers (31/54, 57%) rated Shift highly or very highly.
Conclusions:
Despite high levels of non-response to the post-study assessment and increases in coronavirus safety concerns, junior doctors who used the app reported some improvements in depression and anxiety that warrant further exploration in a robust manner. Clinical Trial: The study was prospectively registered with the Australian New Zealand Clinical Trials Registry under the trial number ACTRN12620000571976.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.